Preoperative transarterial chemoembolization for laparoscopic liver resection in Child A cirrhotic patients with hepatocellular carcinoma

被引:10
作者
Lopez-Lopez, Victor [1 ]
Brusadin, Roberto [1 ]
Lopez-Conesa, Asuncion [1 ]
Capel, Antonio [2 ]
Navarro-Barrios, Alvaro [1 ]
Cayuela, Valentin [1 ]
Lopez-Banet, Elena [3 ]
Garzon-Arana, Alejandro [4 ]
Parrilla-Paricio, Pascual [1 ]
Robles-Campos, Ricardo [1 ]
机构
[1] IMIB ARRIXACA, Clin & Univ Hosp Virgen de la Arrixaca, Dept Gen Visceral & Transplantat Surg, Murcia, Spain
[2] IMIB, Virgen de la Arrixaca Clin & Univ Hosp, Dept Intervent Radiol, Murcia, Spain
[3] IMIB, Virgen de la Arrixaca Clin & Univ Hosp, Dept Radiol, Murcia, Spain
[4] IMIB, Virgen de la Arrixaca Clin & Univ Hosp, Dept Surg Pathol, Murcia, Spain
关键词
Transarterial chemoembolization; Hepatocellular carcinoma; Laparoscopy; Liver resection; HEPATIC RESECTION; LONG-TERM; METAANALYSIS; OUTCOMES;
D O I
10.1007/s00423-020-02056-x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Purpose Laparoscopic liver resection (LLR) for hepatocellular carcinoma (HCC) offers better short-term results than open surgery with similar long-term results although it is technically difficult due to the risk of bleeding. Methods This study included patients with HCC in Child A cirrhosis who underwent TACE before LLR between 2009 and 2019. The primary endpoint was to analyze the intraoperative and early results of this technique. We also analyzed the long-term outcomes. Patients with and without clinically significant portal hypertension (CSPH) were compared. Results A total of 44 cirrhotic patients with HCC were included (24 CSPH and 20 non-CSPH). The Pringle maneuver was used in two cases (4.5%), mean blood losses was 100 ml (range 50-200), and three patients (6.8%) required a blood transfusion. The degree of necrosis achieved was greater than 90% in 27 patients (61.4%). At 1, 3, and 5 years, overall survival was 97.7%, 81.5%, and 63.4%, respectively, and disease-free survival was 85.2%, 52.5%, and 34.5%, respectively. There were no statistically significant differences between non-CSPH and CSPH groups regarding intraoperative, early, and long-term outcomes. Conclusion In our experience, TACE could be beneficial to perform LLR in HCC Child-Pugh A patients with and without CSPH without serious complications and similar oncological outcomes.
引用
收藏
页码:763 / 771
页数:9
相关论文
共 50 条
[21]   Transarterial chemoembolization versus hepatic resection in hepatocellular carcinoma treatment: a meta-analysis [J].
Tian, Xin ;
Dai, Ying ;
Wang, Da-qing ;
Zhang, Li ;
Sui, Cheng-guang ;
Meng, Fan-dong ;
Jiang, Shen-yi ;
Liu, Yun-peng ;
Jiang, You-hong .
DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 :4431-4440
[22]   Influence of Preoperative Transarterial Chemoembolization on the Prognosis for Patients with Resectable Hepatocellular Carcinoma: A Meta-Analysis of Randomized Trials [J].
Wang, Xiaofei ;
Li, Jingdong ;
Peng, Yong ;
Dai, Yi ;
Xu, Wei .
HEPATO-GASTROENTEROLOGY, 2011, 58 (107) :869-874
[23]   Laparoscopic Liver Resection for Hepatocellular Carcinoma [J].
Kim, Ka-Jeong ;
Jeong, Chi-Young ;
Jeong, Sang-Ho ;
Ju, Young-Tae ;
Jung, Eun-Jung ;
Lee, Young-Joon ;
Choi, Sang-Kyung ;
Ha, Woo-Song ;
Park, Soon-Tae ;
Hong, Soon-Chan .
JOURNAL OF THE KOREAN SURGICAL SOCIETY, 2011, 80 (01) :51-55
[24]   Adjuvant transarterial chemoembolization for patients after curative resection of hepatocellular carcinoma: a meta-analysis [J].
Liao, Mingheng ;
Zhu, Zexin ;
Wang, Haichuan ;
Huang, Jiwei .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2017, 52 (6-7) :624-634
[25]   Comparison of prognosis between surgical resection and transarterial chemoembolization for patients with solitary huge hepatocellular carcinoma [J].
Wei, Cheng-Yi ;
Chen, Po-Chun ;
Chau, Gar-Yang ;
Lee, Rheun-Chuan ;
Chen, Ping-Hsien ;
Huo, Teh-Ia ;
Huang, Yi-Hsiang ;
Su, Yu-Hui ;
Hou, Ming-Chih ;
Wu, Jaw-Ching ;
Su, Chien-Wei .
ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (05)
[26]   Laparoscopic ablation therapies or hepatic resection in cirrhotic patients with small hepatocellular carcinoma [J].
Santambrogio, Roberto ;
Bruno, Savino ;
Kluger, Michael D. ;
Costa, Mara ;
Salceda, Juan ;
Belli, Andrea ;
Laurent, Alexis ;
Barabino, Matteo ;
Opocher, Enrico ;
Azoulay, Daniel ;
Cherqui, Daniel .
DIGESTIVE AND LIVER DISEASE, 2016, 48 (02) :189-196
[27]   Efficacy and safety of preoperative transarterial chemoembolization for hepatocellular carcinoma: a systematic review and meta-analysis [J].
Mi, Shizheng ;
Nie, Yang ;
Xie, Changming .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2022, 57 (09) :1070-1079
[28]   Lipiodolized transarterial chemoembolization in hepatocellular carcinoma patients after curative resection [J].
Chen, Xiaohong ;
Zhang, Boheng ;
Yin, Xin ;
Ren, Zhenggang ;
Qiu, Shuangjian ;
Zhou, Jian .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2013, 139 (05) :773-781
[29]   Lipiodolized transarterial chemoembolization in hepatocellular carcinoma patients after curative resection [J].
Xiaohong Chen ;
Boheng Zhang ;
Xin Yin ;
Zhenggang Ren ;
Shuangjian Qiu ;
Jian Zhou .
Journal of Cancer Research and Clinical Oncology, 2013, 139 :773-781
[30]   Laparoscopic liver resection for hepatocellular carcinoma in cirrhotic patients: 10-year single-center experience [J].
Ahmed Shehta ;
Ho-Seong Han ;
Yoo-Seok Yoon ;
Jai Young Cho ;
YoungRok Choi .
Surgical Endoscopy, 2016, 30 :638-648